Study on the mechanism of lupenone for treating type 2 diabetes by integrating pharmacological evaluation and network pharmacology
Context Lupenone (LUP) is the active ingredient of Musa basjoo Sieb. et Zucc. (Musaceae) with antidiabetes effects, but an unclear underlying mechanism of action.Objective Animal experiments combined with network pharmacology were used to explore the mechanism of LUP for treating diabetes.Materials...
Saved in:
Main Authors: | Feng Xu (Author), Mei Zhang (Author), Hongmei Wu (Author), Yuanmin Wang (Author), Ye Yang (Author), Xiangpei Wang (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular mechanism underlying the anti-inflammatory effects of volatile components of Ligularia fischeri (Ledeb) Turcz based on network pharmacology
by: Xulong Huang, et al.
Published: (2020) -
The pharmacological mechanism of chaihu-jia-longgu-muli-tang for treating depression: integrated meta-analysis and network pharmacology analysis
by: Yang Zhao, et al.
Published: (2023) -
Systematic elucidation of the pharmacological mechanisms of Rhynchophylline for treating epilepsy via network pharmacology
by: Hua Geng, et al.
Published: (2021) -
Mechanisms of Dihuang (Rehmanniae Radix) in treating diabetic nephropathy complicated with depression based on network pharmacology
by: Lei Xing, et al.
Published: (2022) -
Integrated Network Pharmacology Analysis and Experimental Validation to Elucidate the Mechanism of Acteoside in Treating Diabetic Kidney Disease
by: Zhang SJ, et al.
Published: (2024)